Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
04/02/1991 | CA1282413C Alkylcarboxamides of pyridylalkylamines, their preparation and their use in human and veterinary medicine |
04/02/1991 | CA1282412C 1-cyclopropyl-6-fluoro-8-bromo-1,4-dihydro-4-oxo-3- quinoline carboxylic acid and derivatives |
04/02/1991 | CA1282411C 1,4,5,6,7,8-hexahydroquinoline compounds |
04/02/1991 | CA1282410C Process for the preparation of optically active ó-arylalkanoic acids and novel intermediates thereof |
04/02/1991 | CA1282409C2 Pyrazolo[4,3-d]pyrimidine derivative, process for its production, antihyperlipidemic agent containing it, its intermediate and process for the production of the intermediate |
04/02/1991 | CA1282408C Process for preparing cephalosporin intermediates |
04/02/1991 | CA1282407C Crystalline cephem carboxylic acid addition salt |
04/02/1991 | CA1282406C Cephalosporin antibiotics |
04/02/1991 | CA1282337C Method for treating drug addiction |
04/02/1991 | CA1282336C Method for eliminating or reducing the desire for smoking |
04/02/1991 | CA1282335C Method for treating the effects of alcohol |
04/02/1991 | CA1282334C 2-¬(3,5-dihalo-4-aminobenzyl)| imidazolines |
04/02/1991 | CA1282333C Nutritional agent for the cerebrospinal nervous system |
04/02/1991 | CA1282332C Preventive drugs for elastosis |
04/02/1991 | CA1282331C Pharmaceutical composition containing cefuroxime axetil |
04/02/1991 | CA1282327C Slow-release pharmaceutical agent |
04/02/1991 | CA1282326C Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient |
04/02/1991 | CA1282321C Emulsifiable concentrates containing azoles |
03/30/1991 | WO1991004746A1 Anti-thrombotic peptides and pseudopeptides |
03/30/1991 | CA2066047A1 Anti-thrombotic peptides and pseudopeptides |
03/30/1991 | CA2026533A1 Biphenylmethane derivative and pharmacological use |
03/30/1991 | CA2026419A1 Cephalosporin compounds |
03/30/1991 | CA2026389A1 Chromene or thiochromene derivatives, process for preparing the same and intermediate therefor |
03/30/1991 | CA2026293A1 Transdermal delivery of (+)(2s,3s)-3-acetoxy-8-chloro-5-(2-dimethylaminoethyl)-2,3- dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4-(5h)-one |
03/30/1991 | CA2026227A1 Heterocyclic compound |
03/30/1991 | CA2025155A1 Extracellular exopolymer, process for its preparation and pharmaceutical compositions containing the said exopolymer |
03/30/1991 | CA2024258A1 Heterocyclic derivatives |
03/29/1991 | CA2026382A1 Inhibitors of retroviral proteases |
03/29/1991 | CA2026381A1 N-aminocarbamates related to physostigmine, a process for their preparation and their use as medicaments |
03/29/1991 | CA2026123A1 Benzodiazepines, their process of production, intermediate products and applications in therapeutic practice |
03/29/1991 | CA2023857A1 Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates |
03/28/1991 | DE4028741A1 New aminoacid derivs. with N-terminal aza-cyclic substit. |
03/28/1991 | DE3936594A1 (gamma)-glutamyl-transferasen zur behandlung von krankheiten (Gamma) glutamyl-transferases for treating diseases |
03/28/1991 | CA2026274A1 Imidazoles |
03/28/1991 | CA2026273A1 Benzanilides |
03/28/1991 | CA2025857A1 Antitumor composition |
03/28/1991 | CA2023930A1 Method for the suppression of bone marrow |
03/27/1991 | WO1991004733A1 Ibuprofen triturates and topical compositions containing same |
03/27/1991 | EP0419411A2 Additional alkanophenones |
03/27/1991 | EP0419410A2 Alkanophenones |
03/27/1991 | EP0419397A1 Substituted urea compounds and their preparation and use |
03/27/1991 | EP0419360A1 Phenothiazine derivatives, their preparation and pharmaceutical compositions containing them |
03/27/1991 | EP0419354A2 Use of a complex of inosine with a N,N-dialkylamino-alkanol or one of its salts with a pharmacologically acceptable acid for the treatment of certain helmintic infections |
03/27/1991 | EP0419327A1 Amino acid derivatives, method for their preparation and their therapeutic application |
03/27/1991 | EP0419312A1 Method for the production of optically active 2-aryl-propionic acids |
03/27/1991 | EP0419311A2 Prodrugs of carbonic anhydrase inhibitors |
03/27/1991 | EP0419308A2 Use of glutamic acid or gum arabic as anti-complement agent |
03/27/1991 | EP0419286A2 Pyridone nitriles useful in treating cardiovascular disease |
03/27/1991 | EP0419247A2 Selective GABA antagonists, especially isoquinoline derivatives, and their use for treating CNS disorders |
03/27/1991 | EP0419237A2 Treatment of non ulcerative dyspepsia with cyproheptadine |
03/27/1991 | EP0419210A1 Novel benzimidazole compounds and their use |
03/27/1991 | EP0419165A2 Preservative for ophthalmic solutions |
03/27/1991 | EP0419157A2 Pharmacologically active compound., preparation and use |
03/27/1991 | EP0419135A2 Use of 1,3-di-n-butyl-7-(2-oxopropyl)xanthine for treating disorders resulting from cerebral ischemia |
03/27/1991 | EP0419132A2 Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
03/27/1991 | EP0419131A2 Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
03/27/1991 | EP0419130A2 Acetylenes disubstituted with a heteroaromatic group and A 2-substituted chromanyl, thiochromanyl or 1,2,3,4- tetrahydroquinolinyl group having retinoid-like activity |
03/27/1991 | EP0419099A1 Proteins having anticoagulant properties |
03/27/1991 | EP0419049A1 (Quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes |
03/27/1991 | EP0419048A2 Substituted pyrimidinones as angiotensin II antagonists |
03/27/1991 | EP0419035A1 Thiazolidine dione derivatives |
03/27/1991 | EP0418990A2 13-Bromo and 13,14-dibromo ergoline, their preparation and their use |
03/27/1991 | EP0418933A1 Derivatives of alcadienes, their preparations and medicinal compositions containing them and intermediates |
03/27/1991 | EP0418924A2 Pyrrolopyrimidines, their production and use |
03/27/1991 | EP0418863A2 NMDA antagonists |
03/27/1991 | EP0418845A1 Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same |
03/27/1991 | EP0418814A2 Isoprenoid phosphinylformic acid squalene synthetase inhibitors and method for preparing the same |
03/27/1991 | EP0418806A1 Pharmaceutical compositions havin activity on the cutaneous microcirculation |
03/27/1991 | EP0418797A2 Pyrimidin-4,6-dicarboxilic acid diamides, process for their preparation also medicine based on those compounds |
03/27/1991 | EP0418716A1 Thienylcarboxylic acid ester of aminoalcohols, their quaternary products, their preparation and use of the compounds |
03/27/1991 | EP0418696A2 Derivatives of aminoacids |
03/27/1991 | EP0418674A1 Pharmaceutical preparations for enhanced absorption of antibacterial compounds |
03/27/1991 | EP0418655A2 Conjugated gamma-hydroxybutenolide compounds and antiulcer agents containing the same as an effective ingredient |
03/27/1991 | EP0418648A1 4-Hydroxytetrahydropyran-2-ones as well as the corresponding dehydroxy carbon acid derivatives, salts and esters, process for their preparation, pharmaceutical preparations as well as precursors |
03/27/1991 | EP0418600A1 Method of making xanthin-derivate pellets |
03/27/1991 | EP0418597A2 Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form |
03/27/1991 | EP0418591A2 (+)-Isomers of endoetheno/endoethano-epoxymorphinan derivatives as antitussive agents |
03/27/1991 | EP0418582A2 Method for treating hypermotility diseases of the bowel employing an ace inhibitor |
03/27/1991 | EP0418565A2 Pulsatile once-a-day delivery system for minocycline |
03/27/1991 | EP0418564A1 Effervescent cold or sinus allergy medicine composition having reduced sodium content |
03/27/1991 | EP0418553A1 High potency, rapidly resorbable glibenclamide preparations, process for their preparation and their use |
03/27/1991 | EP0418524A2 Process for preparing amikacin |
03/27/1991 | EP0418430A1 Phenylalkyl amine derivatives having anti-ischaemic activity |
03/27/1991 | EP0418292A1 Phosphoramides useful as antitumor agents |
03/27/1991 | EP0418248A1 Transdermal multipolymer drug delivery system. |
03/27/1991 | CN1050198A Peptidase and isomerase inhibitors |
03/27/1991 | CN1050196A 4-substituted 17beta-(cyclopropylamino_ androst-5-en-3beta-ol and related compounds useful as c17-20 lyase inhibitors |
03/27/1991 | CN1050195A 4-substituted 17beta-(cyclopropyloxy) androst-5-en-3beta-ol and related compounds usdrul as c17-20 lyase inhigitors |
03/27/1991 | CN1050193A 13-alkyl-23-imino and 13-halo-23-imino derivatives of ll-f28249 compounds and their use as endo-and ectpparasiticidal insecticical, acaricidal and nematocidal agents |
03/27/1991 | CN1050192A Process for preparating antiviral tetrahydroimidazo (1,4) benzodiazepines |
03/27/1991 | CN1050191A Thiazole derivatives, processes for preparation thereof and pharmaceutical composition comprising same |
03/27/1991 | CN1050190A Process for preparing sulphamoylthiophenes |
03/27/1991 | CN1050187A Quinoline compounds and process for preparation therefor |
03/27/1991 | CN1050185A Process for preparing clausenamide and neoclausenamide, and of their derivatives |
03/27/1991 | CN1050183A New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholestrol acyl transferase |
03/27/1991 | CN1050182A Quinone derivatives and pharmacological use |
03/27/1991 | CN1012174B Method for preparing novel 4'-demethy 1-4-epipodophyllotoxin derivatives |
03/27/1991 | CN1012172B Process for preparing pharmic component of sigma-butylmalonamide and its use for pharmacy |
03/27/1991 | CA2067131A1 Ibuprofen triturates and topical compositions containing same |
03/27/1991 | CA2026128A1 Imidazolepropanamide derivatives, preparation and use |